The global autoinjectors market was valued at USD 56.5 billion in 2022 and is expected to reach USD 410 billion by 2032, growing at a compound annual growth rate (CAGR) of 22.1% during the forecast period 2023-2032 .
What is an Autoinjector?
An autoinjector is a special syringe equipped with a spring-loaded needle that is pre-filled with a precise dose of medication. Pressed against the body and activated with a sliding movement, it releases and administers the medicine in a precisely measured dose. Auto-injectors have many benefits, including reducing the fear of needles, minimizing the risk of needle-related events, and other benefits.
Advantages of autoinjectors
Autoinjectors have many advantages, including simplified administration and rapid drug delivery, which are crucial in critical conditions such as anaphylactic shock and opioid overdose. Anaphylactic shock is often caused by factors such as food allergies, insect bites, or drug allergies, and can be fatal if not treated promptly.
Chronic diseases such as cancer, diabetes, and cardiovascular disease represent a significant economic burden, costing the United States approximately $4.1 trillion annually. These diseases contribute significantly to disability and death, with six in ten adults in the United States living with at least one chronic disease in July 2022.
Traditional injection methods have typically relied on syringes, which can be painful tools for drug administration. Consequently, both healthcare professionals and patients are increasingly seeking alternative routes of administration, including oral, nasal and topical applications. In addition, advances in technology have paved the way for the development of needle-free injectors.
Autoinjector Market Segmentation
The autoinjectors market is segmented by therapy such as rheumatoid arthritis (RA), multiple sclerosis, anaphylaxis, diabetes, and others. During the forecast period, the rheumatoid arthritis segment is expected to dominate the market in terms of revenue, primarily due to the increasing prevalence of this disease. Rheumatoid arthritis is the most common form of autoimmune arthritis, affecting approximately 1% of the world’s population.
The North American market is poised to capture the largest share of revenue during the forecast period. This can be attributed to the continuous technological advancement of medical devices, the growing population of diabetics and anaphylaxis, and favorable government policies. The European market is projected to witness steady growth in revenue over the forecast period due to rising investments and expanding healthcare infrastructure. For example, on March 16, 2022, Ipsen announced its investment in a new state-of-the-art electronic autoinjector for Somatuline Autogel/Somatuline Depot (lanreotide) with the goal of improving patient care and improving the dosing and injection process.
Best companies and competitive strategies
Prominent market players are devoting significant resources to their research and development activities aimed at diversifying their product portfolio, which further stimulates the growth of the auto-injectors market. Key Players of Autoinjectors Market: AbbVie Inc., Mylan NV, Lily, Amgen Inc., Ypsomed Holding, BD, Owen Mumford Ltd., Consort Medical, Plc, SHL Medical AG, Johnson Medtech, LLC, Teva Pharmaceuticals USA, Inc. , Antares Pharma, AstraZeneca, Union Medico Inc., Gerresheimer AG and Emergent, among others.
Where to find out more
Be sure to check out the comprehensive new report for more information on the market Global Auto Injectors Market Size, Share and Trend Analysis by Factview Research. This report provides details on the global autoinjectors market size, forecast, segmentation, regional dynamics, industry trends and competitive intelligence.
About Factview research
Factview Research is committed to providing in-depth and cutting-edge insights to companies in a variety of industries. With hundreds of published market research reports, Factview Research not only covers big and disruptive technologies, but also new and niche markets with high growth potential.